Wednesday, June 24, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 877 of 1,261

  1. US 8414910

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  2. US 8415135

    Lactobacillus plantarum and uses thereof

    China Medical University · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  3. US 8415323

    MicroRNAs for inhibiting viral replication

    The Regents of the University of California · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  4. US 8415396

    Colchine compositions and methods

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  5. US 8415314

    Methods for treating multiple sclerosis using antisense oligonucleotides

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  6. US 8414526

    Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids

    Lutonix, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  7. US 8415293

    Peptide mediators of cholesterol efflux

    The Regents of the University of California · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  8. US 8415302

    Surgical applications for BMP binding protein

    The Regents of the University of California · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  9. US 8415097

    Tumor suppressor gene, p47ING3

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  10. US 8415387

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  11. US 8415332

    Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

    Teva Womans's Health, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  12. US 8414909

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  13. US 8414918

    Stable imatinib compositions

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  14. US 8414525

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  15. US 8414876

    Methods of using IL-1 antagonists to treat autoinflammatory disease

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  16. US 8414911

    Photochemical therapy to affect mechanical and/or chemical properties of body tissue

    The Regents of the University of California · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  17. US 8414920

    Pharmaceutical composition containing irbesartan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  18. US 8414908

    Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same

    The Regents of the University of California · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  19. US 8414890

    Human antibodies to human RANKL, encoding nucleic acids and methods of treatment

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  20. US 8415294

    Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth

    THE ARIZONA BOARD OF REGENTS · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  21. US 8415457

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  22. US 8415458

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  23. US 8415365

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  24. US 8415370

    Spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.